LUNA Surges 20% in a Day Amid Ongoing Terra Network Upgrade
- LUNA surged 20% in 24 hours to $0.0868 as Terra network prepares a major upgrade on Dec 8, 2025. - Binance temporarily halted LUNA deposits/withdrawals during the upgrade to ensure protocol stability. - Adverum Biotech reported 90% reduced anti-VEGF injections in LUNA trial for wet AMD, with Phase 3 enrollment nearing completion. - The upgrade and biotech results highlight LUNA's dual impact on crypto markets and medical innovation potential.
LUNA Sees Notable Price Surge
On December 5, 2025, LUNA experienced a sharp 20% increase in value within a single day, reaching $0.0868. Over the past week, the token climbed by 22.99%, maintaining the same growth rate over the past month. However, LUNA has declined by 78.59% over the previous year.
Upcoming Terra Network Upgrade
The Terra blockchain is scheduled for a significant protocol upgrade on December 8, 2025, at block height 18,660,000. To facilitate a smooth transition, Binance will temporarily suspend deposits and withdrawals for LUNA (Terra) starting at 20:05 UTC+8 on the day of the upgrade. The process is anticipated to conclude by approximately 21:05 UTC+8.
This temporary suspension is a routine measure during major blockchain updates to minimize transaction disruptions. Users are encouraged to follow Binance’s official channels for timely updates and notifications regarding the resumption of services.
Adverum Biotechnologies Shares Promising LUNA Trial Results
In a separate development, Adverum Biotechnologies, Inc. announced two-year follow-up data from its LUNA Phase 2 trial of Ixo-vec for patients with wet age-related macular degeneration (AMD) on December 4, 2025. The results revealed an approximate 90% decrease in the need for anti-VEGF injections over two years, while maintaining both anatomical stability and visual acuity across both dosage groups. Notably, the 6E10 dose group reported no new cases of inflammation after week 30. Ixo-vec continues to show a strong safety record.
These positive outcomes support the continued advancement of the therapy, with the Phase 3 ARTEMIS trial expected to complete enrollment by December 5, 2025. Adverum has highlighted Ixo-vec’s potential to revolutionize wet AMD treatment by reducing injection frequency compared to existing therapies.
Summary
LUNA’s recent price rally, the forthcoming Terra network upgrade, and encouraging clinical results from Adverum Biotechnologies are all pivotal factors influencing current market sentiment. The network update is expected to strengthen the blockchain’s long-term resilience, while the biotech company’s progress may enhance the LUNA brand’s reputation beyond the cryptocurrency industry.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Timeless Investment Strategies: Why Insights from 1927 Continue to Shape Today’s Investors
- McNeel's 1927 "Beating the Market" prefigured Buffett's value investing and modern behavioral finance principles. - He advocated emotional discipline and long-term faith in U.S. economic resilience, echoed by Buffett's "margin of safety" strategy. - Modern behavioral finance (2020–2025) validates these insights, showing disciplined investors outperforming during crises like 2008 and 2020. - Algorithmic trading and meme stocks highlight the enduring relevance of McNeel's principles in countering speculati
ICP Network Expansion and Its Impact on Web3 Infrastructure Investments
- ICP Protocol's 2025 growth highlights its role as a hybrid cloud/Web3 infrastructure leader through cross-chain integration and enterprise partnerships. - Unverified 10M node claims contrast with 1.2M wallets, creating transparency concerns for investors assessing network legitimacy. - 22.5% TVL growth and 2,000 new developers signal institutional confidence, yet Q3 dApp usage fell 22.4%, exposing adoption gaps. - Regulatory risks and Web3's user experience challenges question ICP's long-term viability d
SOL Price Forecast and Solana's Market Strength in Late 2025: A Two-Factor Assessment
- Solana (SOL) faces pivotal 2025 juncture with Fed easing and blockchain upgrades driving price resilience. - Fed rate cuts and $421M institutional inflows via ETFs (e.g., REX-Osprey) boost crypto adoption amid low yields. - Firedancer/Alpenglow upgrades cut validator costs by 80%, enabling 100-150ms finality and $10.2B DeFi TVL growth. - $133 support level and bullish TD Sequential signals suggest $150-$165 target by year-end despite inflation risks.
The Federal Reserve's Change in Policy and Its Effects on Rapidly Growing Cryptocurrencies Such as Solana
- Fed's 2025 rate cut and QT halt injected $72.35B liquidity, briefly boosting crypto markets and Solana (+3.01%) amid easing monetary policy. - Prolonged US government shutdown and $19B October liquidation event exposed crypto's liquidity risks, despite Fed support for speculative assets. - Solana saw $3.65B trading volume but 6.1% price drop in November, with TVL falling 4.7% as regulatory pressures and macro volatility offset institutional inflows. - SIMD-0411 proposal aims to reduce Solana issuance by
Trending news
MoreCrypto prices
More
